Cargando…
The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation
Glucose levels inside solid tumors are low as compared with normal surrounding tissue, forcing tumor cells to reprogram their metabolism to adapt to such low glucose conditions. Unlike normal tissue, tumor cells experience glucose starvation, making the targeting of pathways supporting survival duri...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036964/ https://www.ncbi.nlm.nih.gov/pubmed/32033217 http://dx.doi.org/10.3390/ijms21031041 |
_version_ | 1783500316602269696 |
---|---|
author | Marciano, Ran Ben David, Hila Akabayov, Barak Rotblat, Barak |
author_facet | Marciano, Ran Ben David, Hila Akabayov, Barak Rotblat, Barak |
author_sort | Marciano, Ran |
collection | PubMed |
description | Glucose levels inside solid tumors are low as compared with normal surrounding tissue, forcing tumor cells to reprogram their metabolism to adapt to such low glucose conditions. Unlike normal tissue, tumor cells experience glucose starvation, making the targeting of pathways supporting survival during glucose starvation an interesting therapeutic strategy in oncology. Using high-throughput screening, we previously identified small molecules that selectively kill cells exposed to glucose starvation. One of the identified compounds was the kinase inhibitor amuvatinib. To identify new molecules with potential antineoplastic activity, we procured 12 amuvatinib derivatives and tested their selective toxicity towards glucose-starved tumor cells. One of the amuvatinib derivatives, N-(2H-1,3-benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, termed compound 6, was found to be efficacious in tumor cells experiencing glucose starvation. In line with the known dependence of glucose-starved cells on the mitochondria, compound 6 inhibits mitochondrial membrane potential. These findings support the concept that tumor cells are dependent on mitochondria under glucose starvation, and bring forth compound 6 as a new molecule with potential antitumor activity for the treatment of glucose-starved tumors. |
format | Online Article Text |
id | pubmed-7036964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70369642020-03-11 The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation Marciano, Ran Ben David, Hila Akabayov, Barak Rotblat, Barak Int J Mol Sci Article Glucose levels inside solid tumors are low as compared with normal surrounding tissue, forcing tumor cells to reprogram their metabolism to adapt to such low glucose conditions. Unlike normal tissue, tumor cells experience glucose starvation, making the targeting of pathways supporting survival during glucose starvation an interesting therapeutic strategy in oncology. Using high-throughput screening, we previously identified small molecules that selectively kill cells exposed to glucose starvation. One of the identified compounds was the kinase inhibitor amuvatinib. To identify new molecules with potential antineoplastic activity, we procured 12 amuvatinib derivatives and tested their selective toxicity towards glucose-starved tumor cells. One of the amuvatinib derivatives, N-(2H-1,3-benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, termed compound 6, was found to be efficacious in tumor cells experiencing glucose starvation. In line with the known dependence of glucose-starved cells on the mitochondria, compound 6 inhibits mitochondrial membrane potential. These findings support the concept that tumor cells are dependent on mitochondria under glucose starvation, and bring forth compound 6 as a new molecule with potential antitumor activity for the treatment of glucose-starved tumors. MDPI 2020-02-04 /pmc/articles/PMC7036964/ /pubmed/32033217 http://dx.doi.org/10.3390/ijms21031041 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marciano, Ran Ben David, Hila Akabayov, Barak Rotblat, Barak The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation |
title | The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation |
title_full | The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation |
title_fullStr | The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation |
title_full_unstemmed | The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation |
title_short | The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation |
title_sort | amuvatinib derivative, n-(2h-1,3-benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, inhibits mitochondria and kills tumor cells under glucose starvation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036964/ https://www.ncbi.nlm.nih.gov/pubmed/32033217 http://dx.doi.org/10.3390/ijms21031041 |
work_keys_str_mv | AT marcianoran theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation AT bendavidhila theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation AT akabayovbarak theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation AT rotblatbarak theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation AT marcianoran amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation AT bendavidhila amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation AT akabayovbarak amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation AT rotblatbarak amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation |